SOLITARIO ZINC CORP (XPL)

US8342EP1070 - Common Stock

0.58  0 (0%)


Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XPL. XPL was compared to 951 industry peers in the Metals & Mining industry. XPL has a great financial health rating, but its profitability evaluates not so good. XPL has a expensive valuation and it also scores bad on growth

Note: XPL has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

XPL has a Piotroski-F score of 4.00. This indicates an average health and profitability for XPL.

VS Industry

Valuation

Valuation Rating

1

When comparing the current price to the book value of XPL, we can conclude it is valued correctly. It is trading at 1.76 times its book value.
Compared to an average industry price book ratio of 1.57, XPL is valued in line with its industry peers.

The Price/Earnings Ratio is negative for XPL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XPL. No positive earnings are expected for the next year.
VS Industry

Price/Book (1.76) VS Industry: 45% outperformed.

272.66
0.03

Growth

Growth Rating

0

The earnings per share for XPL have decreased strongly by -48.35% in the last year.


PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -48.35% 33.33% N/A N/A N/A
RevenueN/A N/A N/A N/A N/A N/A N/A

Health

Health Rating

8

A Current Ratio of 23.04 indicates that XPL has no problem at all paying its short term obligations.
The Current Ratio of XPL is much better than the industry average of 2.55. XPL has a better rating than 92% of its industry peers.
A Quick Ratio of 23.04 indicates that XPL has no problem at all paying its short term obligations.
The Quick Ratio of XPL is much better than the industry average of 2.08. XPL has a better rating than 92% of its industry peers.

XPL has an Altman-Z score of 62.62. This indicates that XPL is financially healthy and little risk of bankruptcy at the moment.
XPL has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.27. XPL has a better score than 91% of its industry peers.
The Debt to Equity ratio of XPL is in line with the industry averages.
XPL has a Piotroski-F score of 4.00. This indicates an average health and profitability for XPL.
VS Industry

Debt/Equity (0) VS Industry: 53% outperformed.

9.62
0.00

Quick Ratio (23.04) VS Industry: 92% outperformed.

0.00
178.59

Current Ratio (23.04) VS Industry: 92% outperformed.

0.00
178.59

Altman-Z (62.62) VS Industry: 91% outperformed.

-2,971.54
2,354.89

Dividend

Dividend Rating

0

XPL does not give a dividend.

SOLITARIO ZINC CORP

NYSEARCA:XPL (6/2/2023, 2:11:03 PM)

0.58

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-06 2023-03-06/amc
Earnings (Next)N/A N/A
Inst Owners11.63%
Inst Owner Change-7.66%
Ins OwnersN/A
Ins Owner Change0%
Market Cap37.58M
Analysts80
Price Target0.92 (58.62%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.76
P/tB 1.76
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpSN/A
BVpS0.33
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset TurnoverN/A
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1407.41%
Profit Quality N/A
Current Ratio 23.04
Quick Ratio 23.04
Altman-Z 62.62
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1280.37%
Cap/Depr(5y)780.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-48.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q28.45%
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1YN/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-191.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-158.93%
OCF growth 3YN/A
OCF growth 5YN/A
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA